$EYEN
EYENOVIA, INC.

2021 Q4 Form 10-Q Financial Statement

#000110465921138092 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $10.00M $0.00 $0.00
YoY Change 400.0%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $10.00M $0.00
YoY Change 733.33%
Gross Profit Margin 100.0%
Selling, General & Admin $3.712M $2.435M $1.730M
YoY Change 80.17% 40.76% 16.11%
% of Gross Profit 37.12%
Research & Development $3.175M $3.470M $3.364M
YoY Change -5.22% 3.16% 5.12%
% of Gross Profit 31.75%
Depreciation & Amortization $73.31K $73.01K $20.00K
YoY Change 144.37% 265.05%
% of Gross Profit 0.73%
Operating Expenses $6.887M $5.905M $5.092M
YoY Change 27.3% 15.97% 8.57%
Operating Profit $3.113M -$5.905M -$5.092M
YoY Change -173.95% 15.97%
Interest Expense -$185.2K $119.2K $4.945K
YoY Change 2310.76% -87.64%
% of Operating Profit -5.95%
Other Income/Expense, Net $55.19K -$8.010K
YoY Change
Pretax Income $2.983M -$5.569M -$5.100M
YoY Change -170.86% 9.19% 9.68%
Income Tax
% Of Pretax Income
Net Earnings $2.983M -$5.569M -$5.097M
YoY Change -170.86% 9.26% 9.6%
Net Earnings / Revenue 29.83%
Basic Earnings Per Share -$0.21 -$0.23
Diluted Earnings Per Share $106.6K -$0.21 -$0.23
COMMON SHARES
Basic Shares Outstanding 28.40M 26.05M 22.21M
Diluted Shares Outstanding 26.05M 22.21M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.46M $13.50M $22.86M
YoY Change -31.4% -40.94% 24.92%
Cash & Equivalents $19.46M $13.50M $22.86M
Short-Term Investments
Other Short-Term Assets $8.266M $8.701M $2.320M
YoY Change 335.06% 275.03% 648.39%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.99M $23.46M $25.37M
YoY Change -34.15% -7.53% 35.74%
LONG-TERM ASSETS
Property, Plant & Equipment $1.271M $1.413M $360.0K
YoY Change 220.71% 292.56% 414.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $511.0K $119.0K $120.0K
YoY Change 325.82% -0.8% 0.0%
Total Long-Term Assets $9.671M $1.532M $480.0K
YoY Change 1776.29% 219.22% 152.63%
TOTAL ASSETS
Total Short-Term Assets $21.99M $23.46M $25.37M
Total Long-Term Assets $9.671M $1.532M $480.0K
Total Assets $31.66M $24.99M $25.85M
YoY Change -6.63% -3.32% 36.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.614M $1.685M $1.460M
YoY Change 10.43% 15.39% -8.75%
Accrued Expenses $2.327M $1.686M $1.080M
YoY Change -9.81% 56.15% 36.71%
Deferred Revenue $10.00M
YoY Change
Short-Term Debt $0.00 $0.00 $150.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $7.150M $7.282M $150.0K
YoY Change 7050.37% 4754.69%
Total Short-Term Liabilities $11.17M $20.72M $6.740M
YoY Change -38.61% 207.41% 177.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $420.0K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $19.95K $26.06K $40.00K
YoY Change -50.13% -34.85% -20.0%
Total Long-Term Liabilities $19.95K $26.06K $460.0K
YoY Change -95.13% -94.33% 820.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.17M $20.72M $6.740M
Total Long-Term Liabilities $19.95K $26.06K $460.0K
Total Liabilities $11.19M $20.75M $7.200M
YoY Change -39.83% 188.13% 190.32%
SHAREHOLDERS EQUITY
Retained Earnings -$90.22M -$93.20M
YoY Change 16.5%
Common Stock $2.844K $2.597K
YoY Change 13.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.47M $4.246M $18.65M
YoY Change
Total Liabilities & Shareholders Equity $31.66M $24.99M $25.85M
YoY Change -6.63% -3.32% 36.92%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $2.983M -$5.569M -$5.097M
YoY Change -170.86% 9.26% 9.6%
Depreciation, Depletion And Amortization $73.31K $73.01K $20.00K
YoY Change 144.37% 265.05%
Cash From Operating Activities -$5.877M -$5.095M -$1.930M
YoY Change -207.43% 163.97% -50.0%
INVESTING ACTIVITIES
Capital Expenditures -$61.51K -$517.3K -$70.00K
YoY Change 2.52% 639.04% 75.0%
Acquisitions
YoY Change
Other Investing Activities -$391.9K
YoY Change
Cash From Investing Activities -$453.4K -$517.3K -$70.00K
YoY Change 655.75% 639.04% 75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.29M -189.0K 14.69M
YoY Change 13556.72% -101.29% 13.35%
NET CHANGE
Cash From Operating Activities -5.877M -5.095M -1.930M
Cash From Investing Activities -453.4K -517.3K -70.00K
Cash From Financing Activities 12.29M -189.0K 14.69M
Net Change In Cash 5.961M -5.801M 12.69M
YoY Change 8.38% -145.71% 40.07%
FREE CASH FLOW
Cash From Operating Activities -$5.877M -$5.095M -$1.930M
Capital Expenditures -$61.51K -$517.3K -$70.00K
Free Cash Flow -$5.815M -$4.577M -$1.860M
YoY Change -205.16% 146.09% -51.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26052483
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22206195
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25773098
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14997807
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11853369
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25963185
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24978585
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19802999
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Central Index Key
EntityCentralIndexKey
0001682639
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93202584
us-gaap Net Income Loss
NetIncomeLoss
-15761665
us-gaap Net Income Loss
NetIncomeLoss
-15563005
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2646091
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38365
dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1178401
dei Entity Address Address Line1
EntityAddressAddressLine1
295 Madison Avenue, Suite 2400
dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
289-1117
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 Par Value
dei Trading Symbol
TradingSymbol
EYEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28398789
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13500871
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28371828
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7875000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1600000
CY2021Q3 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
960180
CY2020Q4 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
2966039
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1123289
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453478
CY2021Q3 us-gaap Assets Current
AssetsCurrent
23459340
CY2020Q4 us-gaap Assets Current
AssetsCurrent
33391345
us-gaap Operating Income Loss
OperatingIncomeLoss
-16016955
us-gaap Operating Income Loss
OperatingIncomeLoss
-15582607
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1684733
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1461665
CY2021Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1184236
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1150672
CY2021Q3 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
552336
CY2020Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
1480692
CY2021Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
16037
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
7809
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1413201
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
396380
CY2021Q3 us-gaap Security Deposit
SecurityDeposit
119035
CY2020Q4 us-gaap Security Deposit
SecurityDeposit
119035
CY2021Q3 us-gaap Assets
Assets
24991576
CY2020Q4 us-gaap Assets
Assets
33906760
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10000000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14000000
CY2021Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7282037
CY2020Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
97539
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20719379
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18198377
CY2021Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
26059
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
38684
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
365814
CY2021Q3 us-gaap Liabilities
Liabilities
20745438
CY2020Q4 us-gaap Liabilities
Liabilities
18602875
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25963185
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24978585
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2597
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2498
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97446125
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
92742306
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93202584
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77440919
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4246138
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24991576
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33906760
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000000
us-gaap Cost Of Revenue
CostOfRevenue
1600000
us-gaap Net Income Loss
NetIncomeLoss
-15563005
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
us-gaap Gross Profit
GrossProfit
2400000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3470188
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3363759
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11334296
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9913296
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2435141
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1728366
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7082659
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5669311
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5905329
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5092125
us-gaap Operating Expenses
OperatingExpenses
18416955
us-gaap Operating Expenses
OperatingExpenses
15582607
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5905329
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5092125
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
463353
eyen Small Business Administration Economic Injury Disaster Grant
SmallBusinessAdministrationEconomicInjuryDisasterGrant
10000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096530
us-gaap Net Income Loss
NetIncomeLoss
-15761665
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
463353
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8010
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8010
CY2021Q3 us-gaap Interest Expense
InterestExpense
119212
CY2020Q3 us-gaap Interest Expense
InterestExpense
4945
us-gaap Interest Expense
InterestExpense
202407
us-gaap Interest Expense
InterestExpense
14977
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
600
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
540
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2354
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
24579
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5568598
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26053532
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22206195
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25773098
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19802999
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021Q1 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1530990
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656913
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5351667
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
12140121
CY2021Q2 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
573001
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
130090
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
351390
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
637355
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4841400
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
8990557
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46712
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777467
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5568598
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4246138
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
354539
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3149
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11740607
CY2020Q1 eyen Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
5451742
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583865
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5450910
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
12325304
CY2020Q2 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
376421
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
633146
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-5015565
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
8319306
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
231194
CY2020Q3 eyen Stock Issued During Period Value New Issues Three
StockIssuedDuringPeriodValueNewIssuesThree
12495708
CY2020Q3 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2269670
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52137
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
609930
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-5096530
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
18650221
CY2020Q1 eyen Proceeds Of Stock Issued During Period Gross
ProceedsOfStockIssuedDuringPeriodGross
5984931
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
533189
CY2020Q3 eyen Proceeds Of Stock Issued During Period Gross
ProceedsOfStockIssuedDuringPeriodGross
13800002
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1304294
us-gaap Net Income Loss
NetIncomeLoss
-15761665
us-gaap Net Income Loss
NetIncomeLoss
-15563005
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
148245
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71628
eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
41944
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
463353
us-gaap Share Based Compensation
ShareBasedCompensation
2071735
us-gaap Share Based Compensation
ShareBasedCompensation
1826941
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-35549
eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-2005859
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-1600000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1600000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
223068
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-76596
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
33564
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-172318
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-928356
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-106471
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4000000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4000000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-1235
eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-4397
eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1119
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14997807
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11853369
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1165066
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202046
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1165066
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-202046
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5569136
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
12734002
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2103991
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2646091
eyen Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
463353
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7500000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
547259
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
368289
eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
329038
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
66618
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
176802
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
52137
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9166916
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20767392
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6995957
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8711977
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14152601
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21375871
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22864578
eyen Proceeds Of Stock Issued During Period Gross
ProceedsOfStockIssuedDuringPeriodGross
13800002
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1066000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13500871
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22864578
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7875000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21375871
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22864578
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
131839
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
7961
eyen Accrual Of Public Offering Costs
AccrualOfPublicOfferingCosts
-26650
eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
-705360
eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
-475216
eyen Issuance Of Stock Warrants
IssuanceOfStockWarrants
-351390
eyen Percentage Of Success Rate Of Optejet
PercentageOfSuccessRateOfOptejet
0.90
eyen Percentage Of Successful Rate Of Traditional Eye Drops
PercentageOfSuccessfulRateOfTraditionalEyeDrops
0.50
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13500000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7875000
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
21125871
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
28121828
CY2020Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
0
CY2021Q3 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
105941
CY2020Q4 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
0
CY2021Q3 eyen Prepaid Licenses And Subscriptions
PrepaidLicensesAndSubscriptions
31440
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5532163
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5506533
CY2021Q3 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
297494
CY2020Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
151942
CY2021Q3 us-gaap Prepaid Insurance
PrepaidInsurance
413648
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
110094
CY2021Q3 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
30542
CY2020Q4 eyen Prepaid Licenses And Subscriptions
PrepaidLicensesAndSubscriptions
57051
CY2021Q3 eyen Prepaid Patent Expense
PrepaidPatentExpense
34809
CY2021Q3 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
52041
CY2020Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
29403
CY2021Q3 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
77000
CY2020Q4 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
68250
CY2021Q3 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
32254
CY2020Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
25004
CY2021Q3 us-gaap Other Assets
OtherAssets
48120
CY2020Q4 us-gaap Other Assets
OtherAssets
11734
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1123289
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453478
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
895253
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
938873
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
288983
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
211799
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1184236
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1150672
CY2021Q3 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
181241
CY2020Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
348254
CY2021Q3 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
243979
CY2020Q4 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
235355
CY2021Q3 eyen Credit Card Payable
CreditCardPayable
44204
CY2020Q4 eyen Credit Card Payable
CreditCardPayable
50002
CY2021Q3 eyen Accrued Franchise Tax
AccruedFranchiseTax
39300
CY2020Q4 eyen Accrued Franchise Tax
AccruedFranchiseTax
32480
CY2021Q3 eyen Accrued Licensing Fees
AccruedLicensingFees
0
CY2020Q4 eyen Accrued Licensing Fees
AccruedLicensingFees
804447
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
31250
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3068
CY2021Q3 eyen Accrued Expense Reimbursements
AccruedExpenseReimbursements
6441
CY2020Q4 eyen Accrued Expense Reimbursements
AccruedExpenseReimbursements
5459
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5921
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1627
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
552336
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1480692
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
7282037
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2021Q3 us-gaap Notes Payable
NotesPayable
7282037
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
97539
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
365814
CY2020Q4 us-gaap Notes Payable
NotesPayable
463353
us-gaap Interest Expense Debt
InterestExpenseDebt
150349
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2675293
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0081
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.92
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2364074
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777467
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
609930
CY2021Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4305980
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2071735
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1826941
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5787351
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2011313
CY2020Q4 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.43
eyen Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
91884
eyen Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
4.76
eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
877014
eyen Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
2.40
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1226183
CY2021Q3 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.69
eyen Class Of Warrant Or Right Outstanding Weighted Average Remaining Life
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingLife
P4Y
CY2021Q3 eyen Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
2714617
CY2021Q3 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1226183
CY2021Q3 eyen Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
2.69
eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P4Y
CY2021Q3 eyen Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value
ClassOfWarrantOrRightExercisableAggregateIntrinsicValue
2714617
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1226183
eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P4Y
CY2021Q3 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1226183
CY2020Q3 eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1080497
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2300000
CY2021Q3 eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
877014
eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1248161
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.058
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.4696
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2100000
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.04
CY2021Q3 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
34076
CY2020Q3 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
25535
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
144917
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
106021

Files In Submission

Name View Source Status
0001104659-21-138092-index-headers.html Edgar Link pending
0001104659-21-138092-index.html Edgar Link pending
0001104659-21-138092.txt Edgar Link pending
0001104659-21-138092-xbrl.zip Edgar Link pending
eyen-20210930.xsd Edgar Link pending
eyen-20210930x10q.htm Edgar Link pending
eyen-20210930x10q_htm.xml Edgar Link completed
eyen-20210930xex10d1.htm Edgar Link pending
eyen-20210930xex10d2.htm Edgar Link pending
eyen-20210930xex10d3.htm Edgar Link pending
eyen-20210930xex31d1.htm Edgar Link pending
eyen-20210930xex31d2.htm Edgar Link pending
eyen-20210930xex32d1.htm Edgar Link pending
eyen-20210930xex32d2.htm Edgar Link pending
eyen-20210930_cal.xml Edgar Link unprocessable
eyen-20210930_def.xml Edgar Link unprocessable
eyen-20210930_lab.xml Edgar Link unprocessable
eyen-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending